Skip to content

The role of transient receptor potential (TRP) channel proteins in upper airway hyperresponse diseases

The role of transient receptor potential (TRP) channel proteins in upper airway hyperresponse diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094998
Enrollment
Unknown
Registered
2024-12-31
Start date
2023-06-13
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper airway hyperresponsiveness disease

Interventions

NC(6),AR(11),NAR(9):Before the radiofofency ablation of inferior turbinate, appropriate size of inferior turbinate tissue was taken with forceps, the secretions and residual blood on the surface of th

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria for allergic rhinitis refer to the Chinese Guidelines for the Diagnosis and Treatment of Allergic Rhinitis (Revised Edition 2022) and include: (1) Symptoms: two or more of the following symptoms occur: paroxysmal sneezing, watery nose, itchy nose, and nasal congestion. These symptoms persist or accumulate for more than 1 hour per day, and may be accompanied by eye symptoms such as tearing, eye itching and eye redness; (2) Signs: Common signs include nasal mucosa pallor, edema, and nasal watery secretions; (3) Allergen testing: Positive for SPT and/or serum-specific IgE for at least one allergen, or positive for nasal irritation test. Inclusion criteria for patients with non-allergic rhinitis were defined by the European Society of Allergy and Clinical Immunology in 2017 as the presence of at least two nasal symptoms (such as nasal congestion, runny nose, sneezing and/or nasal itchiness) in the nasal mucosa, with no clinical evidence of internal nasal infection and systemic symptoms of sensitization to inhaled allergens.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) 65 years old; (2) Patients with recent history of nasal corticosteroids, decongestants or oral antihistamines and receiving specific immunotherapy (3) Patients with chronic diseases such as diabetes, hypertension, coronary heart disease, lower airway diseases such as asthma and COPD, and systemic diseases such as malignant tumors, liver and kidney insufficiency, and blood system diseases.

Design outcomes

Primary

MeasureTime frame
Expression of TRPV1 and TRPA1 proteins;Expression of neuropeptides and Th2 inflammatory factors;

Countries

China

Contacts

Public ContactDongdong Zhu

China-Japan Union Hospital of Jilin University

zhudd@jlu.edu.cn+86 135 7877 2290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026